- Home
- ROIV vs JXN Comparison
ROIV vs JXN Comparison
Compare ROIV & JXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- JXN
- Stock Information
- Founded
- ROIV 2014
- JXN 1961
- Country
- ROIV United Kingdom
- JXN United States
- Employees
- ROIV N/A
- JXN N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- JXN Life Insurance
- Sector
- ROIV Health Care
- JXN Finance
- Exchange
- ROIV Nasdaq
- JXN Nasdaq
- Market Cap
- ROIV 8.4B
- JXN 6.8B
- IPO Year
- ROIV N/A
- JXN N/A
- Fundamental
- Price
- ROIV $10.68
- JXN $81.60
- Analyst Decision
- ROIV Strong Buy
- JXN Hold
- Analyst Count
- ROIV 8
- JXN 5
- Target Price
- ROIV $17.93
- JXN $92.80
- AVG Volume (30 Days)
- ROIV 4.0M
- JXN 594.9K
- Earning Date
- ROIV 02-10-2025
- JXN 02-19-2025
- Dividend Yield
- ROIV N/A
- JXN 3.92%
- EPS Growth
- ROIV N/A
- JXN 9.11
- EPS
- ROIV N/A
- JXN 11.74
- Revenue
- ROIV $122,585,000.00
- JXN $3,271,000,000.00
- Revenue This Year
- ROIV $15.98
- JXN N/A
- Revenue Next Year
- ROIV N/A
- JXN $3.64
- P/E Ratio
- ROIV N/A
- JXN $6.96
- Revenue Growth
- ROIV 140.04
- JXN 3.55
- 52 Week Low
- ROIV $9.76
- JXN $51.59
- 52 Week High
- ROIV $13.06
- JXN $115.22
- Technical
- Relative Strength Index (RSI)
- ROIV 42.58
- JXN 31.68
- Support Level
- ROIV $10.33
- JXN $89.83
- Resistance Level
- ROIV $10.86
- JXN $98.02
- Average True Range (ATR)
- ROIV 0.27
- JXN 3.48
- MACD
- ROIV 0.02
- JXN -1.02
- Stochastic Oscillator
- ROIV 29.96
- JXN 2.61
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About JXN Jackson Financial Inc.
Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail products offerings comprise annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. It manages the business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments.